Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

0
Player Avatar Julio60 (< 20) Submitted: 10/5/2009 3:31:29 PM : Outperform Start Price: $18.57 REGN Score: +584.90

bullish

Featured Broker Partners


Advertisement